Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

New hybrid compound found to effectively prevent hair loss.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

JAK inhibitors are effective treatments for alopecia areata.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Finasteride increases CD8+ T cells in BPH tissues.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.